Autophagy Dysregulation in Metabolic Associated Fatty Liver Disease: A New Therapeutic Target

Metabolic associated fatty liver disease (MAFLD) is one of the most common causes of chronic liver disease worldwide. To date, there is no FDA-approved treatment, so there is an urgent need to determine its pathophysiology and underlying molecular mechanisms. Autophagy is a lysosomal degradation pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Chun-Liang, Lin, Yu-Cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9456355/
https://www.ncbi.nlm.nih.gov/pubmed/36077452
http://dx.doi.org/10.3390/ijms231710055

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9456355/
https://www.ncbi.nlm.nih.gov/pubmed/36077452
http://dx.doi.org/10.3390/ijms231710055

Ejemplares similares